Lipella Pharmaceuticals Inc.
LIPO
Revenue
136.43k
▼-9.45k▼-6.48%
3 Months ChangeAssets
2.18M
▼-953.05k▼-30.38%
3 Months ChangeLiabilities
480.31k
▼-95.57k▼-16.59%
3 Months ChangeFree Cash Flow
-3.16M
▼-3.16M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001753926-24-001793
2024-10-18
Form 8-K
ID: 0001753926-24-001716
2024-09-11
Form 8-K
ID: 0001753926-24-001565
2024-08-23
Form 8-K
ID: 0001753926-24-001473
2024-08-13
Form 10-Q
ID: 0001753926-24-001419
2024-08-06
Form 8-K
ID: 0001753926-24-001361
2024-08-01
Form 8-K
ID: 0001753926-24-001333
2024-05-09
Form 10-Q
ID: 0001753926-24-000943
2024-04-19
Form 8-K
ID: 0001753926-24-000805
2024-04-12
Form 8-K
ID: 0001753926-24-000721